Tags STEMREGEN

Tag: STEMREGEN

Kalyagen Announces Speaking Engagement at 8th Annual Biohacking Conference in Beverly Hills

eNewsChannels NEWS: -- Kalyagen is pleased to announce that it will be attending and its founder, Christian Drapeau, will be speaking at the upcoming 8th Annual Biohacking Conference. The conference, which is completely sold out, will be held September 15-17 at The Beverly Hilton in Beverly Hills, California.

Kalyagen Announces Attendance at the Fort Lauderdale Open 2022 with Golf Professional Jerrel Gill

eNewsChannels NEWS: -- Kalyagen® is pleased to announce that it will be attending the Fort Lauderdale Open as part of its sponsorship of golf professional Jerrel Gill. The Open will be hosted at the Fort Lauderdale Country Club on May 2-3, 2022.

Paleo f(x) 2022 Conference in Austin: Kalyagen attending and hosting a booth #121

eNewsChannels NEWS: -- Kalyagen is pleased to announce that it will be attending and hosting a booth (#121) at the upcoming Paleo f(x)™ 2022 conference to be held in Austin on April 29 - May 1. STEMREGEN® is a unique and patent-pending blend of proprietary plant-based extracts documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Partnership of Two South Florida PGA Events

eNewsChannels NEWS: -- Kalyagen® is pleased to announce that it is a supporting partner of two upcoming South Florida PGA Section events and golf professional Jerrel Gill. The two events are the South Florida PGA Foundation PGA HOPE Classic on May 12, 2022 and the South Florida Open on June 21-23, 2022.

Kalyagen will be attending and hosting a booth (#215) at the 2022 South by Southwest Wellness Expo

eNewsChannels NEWS: -- Kalyagen is pleased to announce that it will be attending and hosting a booth (#215) at the upcoming South by Southwest® (SXSW®) Wellness Expo. The Wellness Expo is open to all SXSW Badges and is free and open to the public from March 12-13, 2022 from 11 a.m. - 5 p.m. at the Palmer Events Center in Exhibit Halls 1 & 2.

‘Real Husbands of Hollywood’ Returning for Sixth Season to BET

eNewsChannels NEWS: -- Having just returned from Belize to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells, feature actor, comedian, writer and producer Chris Spencer is pleased to announce that everyone's favorite husbands are coming back - the "Real Husbands of Hollywood" has been renewed for a sixth season by BET.

Intelicure Health and Kalyagen Announce Partnership to Distribute STEMREGEN in Canada

eNewsChannels NEWS: -- Kalyagen® and Intelicure Health Inc. announced today that they have entered into an agreement to promote and distribute throughout Canada STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Next ‘The Stemregen Effect’ Commercial Featuring Actor Chris Spencer

eNewsChannels NEWS: -- Kalyagen™ is pleased to announce that the next part of "The Stemregen Effect" digital media campaign will be filmed in Belize and feature actor, comedian, writer and producer Chris Spencer to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Release of ‘The Stemregen Effect’ Commercial with Three Former UCLA Players

eNewsChannels NEWS: -- Kalyagen™ is pleased to announce the release of its "The Stemregen Effect" social media ad featuring former UCLA Bruins and NBA players Niguel Miguel, Marques Johnson and Mitchell Butler to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Clinical Trial Launch to Evaluate STEMREGEN and Stem Cells for Advanced Heart Failure Patients

eNewsChannels NEWS: -- Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the "Spanish Society of Regenerative Medicine and Cell Therapy"), is pleased to announce the launch of a multicenter clinical trial, "The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure," to evaluate the use of stem cell therapies in patients suffering from heart failure.

WHAT'S NEWS